Arsenic trioxide as an anti-tumour agent: mechanisms of action and strategies of sensitization

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Applied Biomedicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2478/V10136-009-0027-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological Responses to Arsenic Compounds*

  2009cited by this paper
• Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.

  2009cited by this paper
• Regulation of genistein-induced differentiation in human acute myeloid leukaemia cells (HL60, NB4) Protein kinase modulation and reactive oxygen species generation.

  2009cited by this paper
• Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells.

  2009cited by this paper
• Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways.

  2008cited by this paper
• Curcumin and cancer: an "old-age" disease with an "age-old" solution.

  2008cited by this paper
• Reactive oxygen species: Current knowledge and applications in cancer research and therapeutic

  2008cited by this paper
• Regulatory Effects of Mammalian Target of Rapamycin-mediated Signals in the Generation of Arsenic Trioxide Responses*

  2008cited by this paper
• Acute promyelocytic leukemia: from highly fatal to highly curable.

  2008influential reference
• Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.

  2008cited by this paper
• Genistein selectively potentiates arsenic trioxide‐induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species‐inducible protein kinases (p38‐MAPK, AMPK)

  2008cited by this paper
• Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.

  2008cited by this paper
• Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.

  2008cited by this paper
• Curcumin as chemosensitizer.

  2007cited by this paper
• Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways.

  2007cited by this paper
• Oxidative stress and apoptosis: impact on cancer therapy.

  2007cited by this paper
• Regulation of inflammation and redox signaling by dietary polyphenols.

  2006cited by this paper
• Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients

  2006cited by this paper
• Using chemopreventive agents to enhance the efficacy of cancer therapy.

  2006cited by this paper
• Retracted: Cisplatin‐induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC‐3 pancreatic tumor xenografts

  2006cited by this paper
• Molecular targets of dietary agents for prevention and therapy of cancer.

  2006cited by this paper
• TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt

  2006cited by this paper
• Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

  2006cited by this paper
• Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors.

  2006cited by this paper
• Pharmacologic inhibitors of extracellular signal‐regulated kinase (ERKs) and c‐Jun NH2‐terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia Cells to arsenic trioxide‐induced apoptosis

  2006cited by this paper
• Pharmacologic inhibitors of PI 3 K / Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells

  2005cited by this paper
• Chemosensitization and Radiosensitization of Tumors by Plant Polyphenols

  2005cited by this paper
• Green Tea Component, Catechin, Induces Apoptosis of Human Malignant B Cells via Production of Reactive Oxygen Species

  2005cited by this paper
• Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells.

  2005cited by this paper
• Phosphoinositide 3‐kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells

  2005cited by this paper
• Inhibition of mitogen‐activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF‐7 cells

  2005cited by this paper
• Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent

  2005cited by this paper
• Insulin Signaling Regulates γ-Glutamylcysteine Ligase Catalytic Subunit Expression in Primary Cultured Rat Hepatocytes

  2004cited by this paper
• 12-O-Tetradecanoylphorbol-13-acetate May Both Potentiate and Decrease the Generation of Apoptosis by the Antileukemic Agent Arsenic Trioxide in Human Promonocytic Cells

  2004cited by this paper
• Following a TRAIL: Update on a ligand and its five receptors

  2004cited by this paper
• Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine

  2004cited by this paper
• Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.

  2003cited by this paper
• Inhibition of Mitochondrial Respiration

  2003cited by this paper
• Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics.

  2002cited by this paper
• The inherent cellular level of reactive oxygen species: One of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide

  2002cited by this paper
• Interaction of genistein with the mitochondrial electron transport chain results in opening of the membrane transition pore.

  2002cited by this paper
• Mechanisms of action of arsenic trioxide.

  2002cited by this paper
• Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis.

  2001cited by this paper
• Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.

  1999cited by this paper
• Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells

  1999cited by this paper
• Regulation of gamma-glutamylcysteine synthetase by protein phosphorylation.

  1996cited by this paper
• Reactions of arsenic(III) and arsenic(V) species with glutathione.

  1993cited by this paper

• Introspecting Scope of Ultra-Diluted Homeopathic Preparations in Human SARS-CoV-2 Infection: A Perspective Review

  2021cites this paper
• Eugenol, a plant-derived phenolic nutraceutical, protects thiol (SH) group in myocardium from ROS-mediated oxidation under chemotherapeutic stress induced by arsenic trioxide – a in vivo model study

  2018cites this paper
• Regeneration of arsenic spent adsorbents by Fe/MgO nanoparticles

  2017cites this paper
• Influence of arsenic trioxide on the expression of cyclin A in the Jurkat cel line

  2016cites this paper
• TRIB3 increases cell resistance to arsenite toxicity by limiting the expression of the glutathione-degrading enzyme CHAC1.

  2016cites this paper
• Targeted Delivery of Arsenic Compounds to Tumor Cells Using Polymeric Micelles

  2016cites this paper
• Cytotoxicity of ascorbate to cancer cells: mathematical modelling, mechanisms and clinical implications

  2015cites this paper
• INFLUENCE OF ARSENIC TRIOXIDE ON THE EXPRESSION OF CYCLIN A IN THE JURKAT CELL LINE WPŁYW TRÓJTLENKU ARSENU NA EKSPRESJĘ CYKLINY A W LINII KOMÓRKOWEJ JURKAT

  2015cites this paper
• Bioactive poly(arsenic) compounds.

  2013cites this paper
• Megadoses of Sodium Ascorbate Efficiently Kill HL60 Cells in Vitro: Comparison with Arsenic Trioxide

  2013cites this paper
• Megadoses of Ascorbate as a New Chemotherapeutic Approach in Uveal Melanoma: A Preliminary In Vitro Investigation

  2013cites this paper
• Phagocytosis of insect haemocytes as a new alternative model

  2012cites this paper
• The age of biomedicine: current trends in traditional subjects

  2011cites this paper